These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23768426)
21. Delusion proneness and emotion appraisal in individuals with high psychosis vulnerability. Szily E; Kéri S Clin Psychol Psychother; 2013; 20(2):166-70. PubMed ID: 22307890 [TBL] [Abstract][Full Text] [Related]
22. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis. Glenthøj LB; Jepsen JR; Hjorthøj C; Bak N; Kristensen TD; Wenneberg C; Krakauer K; Nordentoft M; Fagerlund B Acta Psychiatr Scand; 2017 Mar; 135(3):250-258. PubMed ID: 27988937 [TBL] [Abstract][Full Text] [Related]
23. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Pruessner M; Iyer SN; Faridi K; Joober R; Malla AK Schizophr Res; 2011 Jun; 129(1):29-35. PubMed ID: 21497058 [TBL] [Abstract][Full Text] [Related]
24. Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study. O'Connor JA; Wiffen B; Diforti M; Ferraro L; Joseph C; Kolliakou A; Bonaccorso S; Murray RM; David AS Schizophr Res; 2013 Sep; 149(1-3):70-6. PubMed ID: 23815972 [TBL] [Abstract][Full Text] [Related]
25. Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia. Cicero DC; Klaunig MJ; Trask CL; Neis AM Schizophr Res; 2016 Oct; 176(2-3):456-461. PubMed ID: 27562615 [TBL] [Abstract][Full Text] [Related]
26. Impact of emotion dysregulation and cognitive insight on psychotic and depressive symptoms during the early course of schizophrenia spectrum disorders. Liu J; Chan TCT; Chong SA; Subramaniam M; Mahendran R Early Interv Psychiatry; 2020 Dec; 14(6):691-697. PubMed ID: 31692276 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Yung AR; Phillips LJ; Yuen HP; McGorry PD Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872 [TBL] [Abstract][Full Text] [Related]
28. Altered activation and functional connectivity of neural systems supporting cognitive control of emotion in psychosis proneness. Modinos G; Ormel J; Aleman A Schizophr Res; 2010 May; 118(1-3):88-97. PubMed ID: 20188516 [TBL] [Abstract][Full Text] [Related]
29. The Role of Personal Identity on Positive and Negative Symptoms in Psychosis: A Study Using the Repertory Grid Technique. García-Mieres H; Villaplana A; López-Carrilero R; Grasa E; Barajas A; Pousa E; Feixas G; Ochoa S Schizophr Bull; 2020 Apr; 46(3):572-580. PubMed ID: 32275754 [TBL] [Abstract][Full Text] [Related]
30. Affective dysfunctions in adolescents at risk for psychosis: emotion awareness and social functioning. van Rijn S; Schothorst P; Wout Mv; Sprong M; Ziermans T; van Engeland H; Aleman A; Swaab H Psychiatry Res; 2011 May; 187(1-2):100-5. PubMed ID: 21094533 [TBL] [Abstract][Full Text] [Related]
31. Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocol. Thomas N; Farhall J; Foley F; Rossell SL; Castle D; Ladd E; Meyer D; Mihalopoulos C; Leitan N; Nunan C; Frankish R; Smark T; Farnan S; McLeod B; Sterling L; Murray G; Fossey E; Brophy L; Kyrios M BMC Psychiatry; 2016 Sep; 16(1):312. PubMed ID: 27604363 [TBL] [Abstract][Full Text] [Related]
32. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109 [TBL] [Abstract][Full Text] [Related]
33. Self-esteem and Symptoms in Individuals at Clinical High Risk for Psychosis. Benavides C; Brucato G; Kimhy D J Nerv Ment Dis; 2018 Jun; 206(6):433-438. PubMed ID: 29781891 [TBL] [Abstract][Full Text] [Related]
34. Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach. Lien YJ; Chang HA; Kao YC; Tzeng NS; Lu CW; Loh CH Epidemiol Psychiatr Sci; 2018 Apr; 27(2):176-185. PubMed ID: 27974084 [TBL] [Abstract][Full Text] [Related]
35. The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Bentall RP; Rowse G; Shryane N; Kinderman P; Howard R; Blackwood N; Moore R; Corcoran R Arch Gen Psychiatry; 2009 Mar; 66(3):236-47. PubMed ID: 19255373 [TBL] [Abstract][Full Text] [Related]
36. Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis. Faerden A; Barrett EA; Nesvåg R; Friis S; Finset A; Marder SR; Ventura J; Andreassen OA; Agartz I; Melle I Psychiatry Res; 2013 Nov; 210(1):55-61. PubMed ID: 23489592 [TBL] [Abstract][Full Text] [Related]
37. Is living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 year. Cavelti M; Rüsch N; Vauth R J Nerv Ment Dis; 2014 Jul; 202(7):521-9. PubMed ID: 24933416 [TBL] [Abstract][Full Text] [Related]
38. Social and non-social measures of cognition for predicting self-reported and informant-reported functional outcomes in early psychosis. Vidarsdottir OG; Twamley EW; Roberts DL; Gudmundsdottir B; Sigurdsson E; Magnusdottir BB Scand J Psychol; 2019 Aug; 60(4):295-303. PubMed ID: 31111499 [TBL] [Abstract][Full Text] [Related]
39. Influences on functional outcome and subjective recovery in individuals with and without First Episode Psychosis: A metacognitive model. Wright A; Fowler D; Greenwood K Psychiatry Res; 2020 Feb; 284():112643. PubMed ID: 31718807 [TBL] [Abstract][Full Text] [Related]
40. Factors influencing subjective recovery of people with recent-onset psychosis: A cross-sectional study in a low-income sub-Saharan country. Temesgen WA; Chien WT; Bressington D Psychiatry Res; 2020 May; 287():112282. PubMed ID: 30853117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]